These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9402095

  • 1. Anemia in hemodialysis patients: variables affecting this outcome predictor.
    Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, Owen WF.
    J Am Soc Nephrol; 1997 Dec; 8(12):1921-9. PubMed ID: 9402095
    [Abstract] [Full Text] [Related]

  • 2. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
    Pollak VE, Lorch JA, Shukla R, Satwah S.
    BMC Nephrol; 2009 Feb 26; 10():6. PubMed ID: 19245700
    [Abstract] [Full Text] [Related]

  • 3. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK, Morgenstern T.
    Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O, Dawood M, Friedman EA.
    Nephron; 1997 Sep 03; 77(3):315-8. PubMed ID: 9375826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D, Johnson CA, Wish JB, Rocco MV, Madore F, Owen WF.
    Kidney Int; 2000 Feb 03; 57(2):578-89. PubMed ID: 10652035
    [Abstract] [Full Text] [Related]

  • 9. Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.
    Tarng DC, Huang TP, Chen TW.
    Am J Nephrol; 1997 Feb 03; 17(2):158-64. PubMed ID: 9096447
    [Abstract] [Full Text] [Related]

  • 10. Multifactorial analysis of renal anemia-associated substandard hemoglobin levels and prevalence of anemia in patients on maintenance hemodialysis in Liaoning Province: a cross-sectional study.
    Yin S, Du Y, Guo Y, Guo G, Sun D, Yao L.
    Ann Palliat Med; 2022 Dec 03; 11(12):3743-3754. PubMed ID: 36635999
    [Abstract] [Full Text] [Related]

  • 11. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O, Feldman J, Friedman EA.
    N Engl J Med; 1996 Feb 15; 334(7):420-5. PubMed ID: 8552143
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003 Feb 15; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

  • 13. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar 15; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 14. Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM - HD Study.
    Kuo KL, Hung SC, Tseng WC, Tsai MT, Liu JS, Lin MH, Hsu CC, Tarng DC, Taiwan Society of Nephrology Renal Registry Data System.
    J Am Heart Assoc; 2018 Aug 07; 7(15):e009206. PubMed ID: 30371224
    [Abstract] [Full Text] [Related]

  • 15. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr 07; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 16. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V.
    Rev Med Chil; 1990 Jun 07; 118(6):629-34. PubMed ID: 1775783
    [Abstract] [Full Text] [Related]

  • 17. C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
    Owen WF, Lowrie EG.
    Kidney Int; 1998 Aug 07; 54(2):627-36. PubMed ID: 9690231
    [Abstract] [Full Text] [Related]

  • 18. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials.
    Ornt DB, Larive B, Rastogi A, Rashid M, Daugirdas JT, Hernandez A, Kurella Tamura M, Suri RS, Levin NW, Kliger AS, Frequent Hemodialysis Network Trial Group.
    Nephrol Dial Transplant; 2013 Jul 07; 28(7):1888-98. PubMed ID: 23358899
    [Abstract] [Full Text] [Related]

  • 19. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
    Kobayashi H, Abe M, Okada K, Tei R, Maruyama N, Kikuchi F, Higuchi T, Soma M.
    Nutrients; 2015 May 15; 7(5):3783-95. PubMed ID: 25988769
    [Abstract] [Full Text] [Related]

  • 20. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ.
    Am J Nephrol; 2000 May 15; 20(6):455-62. PubMed ID: 11146312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.